RSS   Newsletter   Contact   Advertise with us
Post Online Media

Calithera appoints Suzy Jones to board of directors

CalitheraCalithera Biosciences, Inc., a clinical-stage pharmaceutical company, appoints Suzy Jones to the board of directors, where she will be a member of the company’s audit committee.
Article continues below

READ MORE Calithera Biosciences announces key management changes

Ms. Jones is currently Founder and Managing Partner of DNA Ink, a boutique life sciences advisory firm.

Prior to founding DNA Ink, Ms. Jones spent 20 years at Genentech in various roles in immunology research, product development managing cross functional teams for Rituxan and Avastin, and business development where she was Head of Non-Oncology Licensing and later Interim Head of Partnering and Head of Business Development.

In 2010, she was named by Black Health Magazine as one of the, “Top 25 Most Influential African Americans in Healthcare, Medicine, Pharmaceutical and Food Industries.”

Ms. Jones serves as a member of the board of directors of Patrys, an ASX listed Australian biotechnology company.

She received a degree in Biology from University of California, Santa Cruz.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy